Symptomtext
patient received only the liquid DTAP-IPV portion, no AE; Initial information received on 01-Dec-2021 regarding an unsolicited valid non-serious case from a other healthcare professional and nurse via Agency (under reference number 00880090). This case involves a 2 months old male patient who received only the liquid dtap-ipv portion of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (product preparation issue). The patient's medical history, medical treatment(s) and family history were not provided. No other vaccines/ concomitants were given to patient. On 01-Dec-2021, the patient received a 0.5ml first dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE (lot number UJ529AA and expiry date 22-Jul-2022, 30-Jun-2022, standard, once) via intramuscular route in the right leg for prophylactic vaccination. It was an actual medication error due to inappropriate reconstitution technique (same day latency). It was reported "Registered Nurse (RN) calling on PENTACEL. Caller states a patient received only the liquid DTAP-IPV portion of the vaccine and would like to know if that is a valid dose? Caller would also like to know if they can still administer the ACTHIB portion separately? Agent directed caller to visit pentacel.com for vaccine preparation guidance." At time of reporting, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.